ClinicalTrials.gg
Status unknownNCT03753984Updated Jul 15, 2019

Effects of Low-level Laser Therapy in the Fatigue Muscle of Healthy Individual and Spastic Individuals

An interventional study of Low-level laser therapy in Fatigue and Stroke Sequelae, sponsored by Universidade do Vale do Paraíba. Status unknown at 1 site in Brazil. Open to participants aged 20 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-07-15.

Sponsored by Universidade do Vale do Paraíba · Not applicable, Interventional, and Treatment

How we know

The sponsor has not verified this record recently (last verified Nov 2018), so the status shown — last known as Recruiting — may be out of date.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
20 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 57 studies in Fatigue with a site in Brazil — 9 open to participants now, 13 under way, 2 of them phase 3. Fatigue · Brazil.

Planned enrollment
20th of 54
50 · median 40
Started
2018
with 2 others
No phase
44 of 57
5 open now
Registered
29th of 57
by date

Among the 57 studies in Fatigue with a site in Brazil, this one is the 20th largest by planned enrollment of the 54 interventional ones that give a count, is one of 3 that started in 2018, is one of 44 with no phase, and was the 29th registered.

Fatigue

2,234 studies on the registry are indexed under Fatigue; 430 are open to participants now.

Browse Fatigue studies →

Open to participants now

9 of the 57 studies in Fatigue with a site in Brazil are open now. Recruiting first, the newest first:

4 more — sign in →

All 9 open studies →

A study can be open while its sites in Brazil have not opened yet or have stopped. Only those recruiting at a site in Brazil →

Who these studies take

Of the 242 Fatigue studies recruiting now, 113 (47%) set no upper age limit and 99 (41%) stop at 75 or younger; 23 take children under 18; 74 take healthy volunteers.

This study: 20 Years to 80 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 57 studies in Fatigue with a site in Brazil, or all of them as a file.
02

Study summary

Muscle fatigue is caused by biochemical changes that modify the mechanics of muscle contraction, which result in negative changes in the performance of the contraction. The objective of this study is to evaluate the effects of LLLT on brachial biceps muscle fatigue in healthy individuals and individuals with spastic hemiparesis. The study will consist of three groups (Control Group, Placebo Group and LLLT Group) and all individuals will go through all groups, following the criteria of randomization. The protocol consists of LLLT application in the dominant side brachialis muscle in healthy subjects and on the hemiparetic side of post-stroke individuals, prior to performing the Isometric Maximum Voluntary Contraction (IMVC) for 50 seconds in the isokinetic dynamometer. Will be evaluated pain, myoelectric activity associated with muscular torque, local temperature and blood lactate concentration.

Read the detailed description

Muscle fatigue is caused by biochemical changes that modify the mechanics of muscle contraction, which result in negative changes in the performance of the contraction. Several resources are studied in order to mitigate this situation, among them we can mention the Low Level-Laser Therapy (LLLT), which has demonstrated positive effects in the treatment of muscle disorders and fatigue prevention. The effects of LLLT are being studied in healthy individuals with fibromyalgia and athletes, currently studies are being performed on spastic muscles with post-stroke patients (post-stroke). The objective of this study is to evaluate the effects of LLLT on brachial biceps muscle fatigue in healthy individuals and individuals with spastic hemiparesis. A double-blind, cross-sectional, comparative, randomized, double-blind clinical trial will be conducted. Phase I will consist of 30 healthy individuals and Phase II will be composed of 30 post-stroke individuals. The study will consist of three groups (Control Group, Placebo Group and LLLT Group) and all individuals will go through all groups, following the criteria of randomization. The protocol consists of LLLT application in the dominant side brachialis muscle in healthy subjects and on the hemiparetic side of post-stroke individuals, prior to performing the Isometric Maximum Voluntary Contraction (IMVC) for 50 seconds in the isokinetic dynamometer. The pain intensity will be evaluated through the Visual Analog Pain Scale, the myoelectric activity through the surface electromyography associated with the evaluation of the muscular torque through the isokinetic dynamometer. The local temperature will be evaluated by infrared thermography and blood lactate concentration by means of the lactimeter, which will be measured at four different times, prior to the application of the laser (basal collection) and 3, 15 and 25 minutes after IMVC.

03

Conditions studied

  • Fatigue
  • Stroke Sequelae

Browse trials for

Keywords

  • Fatigue
  • Low-level Laser Therapy
  • Stroke
  • Infrared thermograpy
04

Who can participate

Ages eligible
20 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

  • Inclusion Criteria (Healthy group):

    • Preserved cognition, and preservation of the ability to respond to verbal stimul;
    • To present the "insufficient active" or "active" indices on the scale of the International Questionnaire of Physical Activity.
  • Inclusion Criteria (Post stroke group):

    • Individuals with medical diagnosis of stroke;
    • Individuals with physiotherapeutic diagnosis of spastic hemiparesis with brachial predominance;
    • Preserved cognition and preservation of the ability to respond to verbal stimuli;
    • Injury time: after 12 months;
    • Patients with a maximum of 2 degree spasticity according to the Modified Ashworth Scale and minimum muscle strength of 1 in the biceps brachii muscle.
  • Exclusion Criteria (Healthy group):

    • Possess musculoskeletal impairment of the dominant upper limb;
    • Practice physical activity with load (bodybuilding);
    • Presence of active infection and eruptions in the dominant upper limb;
    • Limiting pain that makes it impossible to perform the evaluation protocol;
    • Ingestion of analgesic and / or anti-inflammatory drugs and / or drugs containing or steroids.
    • Fitzpatrick classification: Phototypes V and VI;
    • Presence of malignant neoplastic lesion;
    • Presence of active infection and eruptions at the electrode application site;
    • Hypoesthesia and / or hyperesthesia and / or anesthesia of the limb in which TLBI will be applied.
  • Exclusion Criteria (Healthy group):

    • Presence of active infection and eruptions in the dominant upper limb;
    • Limiting pain that makes it impossible to perform the evaluation protocol;
    • Ingestion of analgesic and / or anti-inflammatory drugs and / or drugs containing corticosteroids or steroids.
    • Fitzpatrick classification: Phototypes V and VI;
    • Presence of malignant neoplastic lesion;
    • Presence of active infection and eruptions at the electrode application site;
    • Hypoesthesia and / or hyperesthesia and / or anesthesia of the limb to be treated;
    • Muscular contractures and joint deformities;
    • Uncontrolled arterial hypertension;
    • Individuals with other associated neurological and / or orthopedic disorders;
    • Wernick or Broca's aphasia.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Healthy group

    The protocol consists of Low-level laser therapy (LLLT) application in the dominant side brachialis muscle in healthy subjects prior to performing the Isometric Maximum Voluntary Contraction (IMVC) for 50 seconds in the isokinetic dynamometer and will be analize Visual Analog Pain Scale, electromyography associated with the evaluation of the muscular torque through the isokinetic dynamometer, local infrared thermography and blood lactate concentration by means of the lactimeter, which will be measured at four different times, prior to the application of the laser (basal collection) and 3, 15 and 25 minutes after IMVC. All the participants will pass for three groups: Control group (not will be applicate LLLT), Placebo group (laser will be off) and LLLT group (will be applicate LLLT).

    Other: Low-level laser therapy

  • Experimental
    Post stroke group

    The protocol consists of Low-level laser therapy (LLLT) application in the hemiparetic side brachialis muscle post stroke individuals prior to performing the Isometric Maximum Voluntary Contraction (IMVC) for 50 seconds in the isokinetic dynamometer and will be analize Visual Analog Pain Scale, surface electromyography with the evaluation of the muscular torque through the isokinetic dynamometer, local infrared thermography and blood lactate concentration, which will be measured at four different times, prior to the application of the laser (basal collection) and 3, 15 and 25 minutes after IMVC. All the participants will pass for three groups: Control group (not will be applicate LLLT), Placebo group (laser will be off) and LLLT group (will be applicate LLLT).

    Other: Low-level laser therapy

Interventions

  • OtherLow-level laser therapy

    In both arms will be applied Low-level laser therapy and induced muscle fatigue.

06

What researchers measure

Primary outcomes

  1. Changes in pain sensation

    To analize the pain. The scale is composed of a horizontal line with a scale of 0 to 10, with 0 representing no pain and 10 representing the worst possible pain.

    Time frame: Baseline (before test) and will be assessed from the beginning to the end of the test (50 seconds).

  2. Surface electromyograph

    To analize the myoelectric activity. The surface electrodes will be placed in pairs on the muscular belly of the biceps and triceps brachii muscles, following the longitudinal direction of the muscle fibers.

    Time frame: Will be assessed from the beginning to the end of the test (50 seconds).

  3. Analyze the behavior of the local temperature (Infra-red thermography)

    To analize the local temperature.

    Time frame: Baseline (Before test) and will be assessed from the beginning to the end of the test (50 seconds).

  4. To evaluate changes in lactate concentration through lactimeter.

    A collection of blood lactate levels will be performed at four different times.

    Time frame: Baseline (before test) and after the test (3, 15 and 25 minutes after the test)

  5. Isokinetic dynamometer

    To analize muscle torque

    Time frame: Will be assessed from the beginning to the end of the test (50 seconds).

07

Study locations

1 of 1 sites recruiting
  • Universidade do Vale do Paraiba
    São José Dos Campos, São Paulo 12.244-000, Brazil
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Sep 2018 to primary completion in Jun 2019, 9 months.

Of 937 non-industry interventional studies with no phase under Fatigue, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 27. This study's 9 months is below that.

Counting every sponsor, half of 990 studies reached it within 12 months; a quarter within 5 and three quarters within 27.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 31, 2018
First posted
Nov 27, 2018
StartActual
Sep 1, 2018
Primary completionActual
Jun 1, 2019
CompletionEst.
Mar 1, 2020
Last update
Jul 15, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 15, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03753984
Lead sponsor
Universidade do Vale do Paraíba
Responsible party
Sponsor
First posted
Nov 27, 2018
Start date
Sep 1, 2018
Primary completion
Jun 1, 2019
Completion
Mar 1, 2020 (estimated)
Last update
Jul 15, 2019

Study contacts

Gabriela S Souza
Contact
gabrielasouza507@yahoo.com.br
5512997232806
Gabriela S Souza
Contact
fpupio@univap.br
5512997232806
Fernanda P Lima, Doctor
principal investigator · Universidade do Vale do Paraíba

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion